Molecular and clinical traits of HER2-low breast cancer patients and their relationship with neoadjuvant treatment effectiveness
Our investigation highlights the possibility that HER2-low breast cancer may indicate a unique clinical and biological phenomenon.
Authors
- Yueyin Pan (ORCID: https://orcid.org/0000-0003-0532-5368)
- Wei Zhao (ORCID: https://orcid.org/0000-0001-6732-9466)
- Bohui Zhu (ORCID: https://orcid.org/0000-0002-9523-6520)
- Yiyuan Sun (ORCID: https://orcid.org/0000-0003-3152-6817)
- Mingxiang Zhang
Institutions
- University of Science and Technology of China (CN)
- Second Military Medical University (CN)
- Shanghai Pudong New Area Gongli Hospital (CN)
Publication Details
- Journal
- European Journal of Cancer Prevention
- Published
- 2024-09-16
- DOI
- https://doi.org/10.1097/cej.0000000000000924
- Citations
- 1
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.28